{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:08:13Z","timestamp":1787317693827,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To define the role of adjuvant therapy in duodenal adenocarcinoma (DAC) and intestinal subtype ampullary carcinoma (iAC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>DAC and iAC share a similar histologic differentiation but the benefit of adjuvant therapy remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients undergoing curative intent surgical resection for DAC and iAC between 2010 and 2021 at 5 high-volume centers were included. Patient baseline, perioperative, and long-term oncological outcomes were evaluated. Statistical testing was performed with SPSS 25 (IBM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 136 patients with DAC and 171 with iAC were identified. Patients with DAC had more advanced tumors than those with iAC. Median overall survival (OS) in patients with DAC was 101 months versus 155 months for patients with iAC (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.098). DAC had a higher rate of local (14.1% vs 1.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and systemic recurrence (30.4% vs 3.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Adjuvant therapy failed to improve OS in all patients with DAC and iAC. For DAC, patients with perineural invasion, but not other negative prognostic factors, had improved OS rates with adjuvant therapy (72 vs 44\u00a0m,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.044). Patients with iAC with N+ (190 vs 57\u00a0m,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.003), T3-T4 (177 vs 59\u00a0m,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.050), and perineural invasion (150 vs 59\u00a0m,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.019) had improved OS rates with adjuvant therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>While adjuvant therapy fails to improve OS in all patients with DAC and iAC in the current study, it improved OS in patients with DAC with perineural invasion and in patients with iAC with T3-T4 tumors, positive lymph nodes, and perineural invasion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000006129","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:00:42Z","timestamp":1697173242000},"page":"986-992","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Role of Adjuvant Therapy in Duodenal Adenocarcinoma and Intestinal Subtype Ampullary Carcinoma After Curative Resection"],"prefix":"10.1097","volume":"280","author":[{"given":"Sarah","family":"Finton","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Bolm","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"},{"name":"Department of Surgery, University Medical Center Schleswig-Holstein, Campus L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Nebbia","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"},{"name":"Department of Surgery, Unit of Pancreatic Surgery, Humanitas Research Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Petruch","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"},{"name":"Department of Surgery, University Medical Center Schleswig-Holstein, Campus L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"F\u00e9rnandez-Del Castillo","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motaz","family":"Qadan","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Lillemoe","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich F.","family":"Wellner","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Schleswig-Holstein, Campus L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Distler","sequence":"additional","affiliation":[{"name":"Department for Visceral, Thoracic and Vascular Surgery, University Hospital, Technical University Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Department for Visceral, Thoracic and Vascular Surgery, University Hospital, Technical University Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Weitz","sequence":"additional","affiliation":[{"name":"Department for Visceral, Thoracic and Vascular Surgery, University Hospital, Technical University Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"R\u00fcckert","sequence":"additional","affiliation":[{"name":"Department of Surgery, Diakonissen Hospital Speyer, Speyer, Germany"},{"name":"Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuh N.","family":"Rahbari","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Reissfelder","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Nappo","sequence":"additional","affiliation":[{"name":"Pancreatic Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Keck","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical Center Schleswig-Holstein, Campus L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zerbi","sequence":"additional","affiliation":[{"name":"Pancreatic Surgery Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Ferrone","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA"},{"name":"Department of Surgery, Cedars\u2019 Sinai Medical Center, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9610(00)00405-0","article-title":"Factors influencing survival after resection for periampullary neoplasms","volume":"180","author":"Bouvet","year":"2000","journal-title":"Am J Surg"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4240\/wjgs.v8.i3.212","article-title":"Duodenal adenocarcinoma: advances in diagnosis and surgical management","volume":"8","author":"Cloyd","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/ans.12112","article-title":"Long\u2010term outcomes in patients with duodenal adenocarcinoma","volume":"84","author":"Lee","year":"2014","journal-title":"ANZ J Surg"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"85","DOI":"10.23736\/S1121-421X.18.02543-6","article-title":"Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: a Surveillance, Epidemiology, and End Results (SEER) cohort study","volume":"65","author":"Ramai","year":"2019","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"12676","DOI":"10.1038\/s41598-019-49179-w","article-title":"The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma","volume":"9","author":"Zimmermann","year":"2019","journal-title":"Sci Rep"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pan.2020.01.009","article-title":"Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy\u2014a multicenter cohort study","volume":"20","author":"Bolm","year":"2020","journal-title":"Pancreatol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/1471-2407-13-428","article-title":"Intestinal type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary, and duodenal origin","volume":"13","author":"Bronsert","year":"2013","journal-title":"BMC Cancer"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jso.25336","article-title":"Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012","volume":"119","author":"Hester","year":"2019","journal-title":"J Surg Oncol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamasurg.2019.1170","article-title":"Role of adjuvant multimodality therapy after curative-intent resection of ampullary carcinoma","volume":"154","author":"Ecker","year":"2019","journal-title":"JAMA Surg"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11605-011-1704-6","article-title":"Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma","volume":"16","author":"Cecchini","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s11605-011-1808-z","article-title":"15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas","volume":"16","author":"Onkendi","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archsurg.142.3.285","article-title":"Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum","volume":"142","author":"Swartz","year":"2007","journal-title":"Arch Surg"},{"key":"R13-20250503","article-title":"Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma: International Multicenter Cohort Study","author":"Moekotte","year":"2019","journal-title":"Ann Surg"},{"key":"R14-20250503","first-page":"234","article-title":"Malignant neoplasia of normally situated and heterotopic lymphoid tissue and its numerical microscopic grading","volume":"49","author":"Broders","year":"1953","journal-title":"Tex State J Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.surg.2007.02.001","article-title":"Postpancreatectomy hemorrhage (PPH)\u2013an international study group of pancreatic surgery (ISGPS) definition","volume":"142","author":"Wente","year":"2007","journal-title":"Surgery"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.surg.2007.05.005","article-title":"Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)","volume":"142","author":"Wente","year":"2007","journal-title":"Surgery"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5507\/bp.2021.028","article-title":"Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes","volume":"166","author":"Tesarikova","year":"2022","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czechoslov"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4251\/wjgo.v9.i10.407","article-title":"Ampullary cancer of intestinal origin and duodenal cancer\u2014a logical clinical and therapeutic subgroup in periampullary cancer","volume":"9","author":"Chandrasegaram","year":"2017","journal-title":"World J Gastrointest Oncol"},{"key":"R20-20250503","first-page":"6491049","article-title":"Prognostic factors and clinical characteristics of patients with primary duodenal adenocarcinoma: a single-center experience from China","author":"Jiang","year":"2016","journal-title":"BioMed Res Int"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1245\/s10434-018-6567-6","article-title":"Outcomes and treatment options for duodenal adenocarcinoma: a systematic review and meta-analysis","volume":"25","author":"Meijer","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/bjs.9791","article-title":"Outcome after surgical resection for duodenal adenocarcinoma in the UK","volume":"102","author":"Solaini","year":"2015","journal-title":"J Br Surg"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/SLA.0b013e31817b6609","article-title":"Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization","volume":"248","author":"van Roest","year":"2008","journal-title":"Ann Surg"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4251\/wjgo.v3.i3.33","article-title":"Epidemiology of cancer of the small intestine","volume":"3","author":"Pan","year":"2011","journal-title":"World J Gastrointest Oncol"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/jcm11092367","article-title":"Perineural invasion in pancreatic ductal adenocarcinoma (PDAC): a saboteur of curative intended therapies?","volume":"11","author":"Felsenstein","year":"2022","journal-title":"J Clin Med"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3390\/cancers14235793","article-title":"Perineural invasion in pancreatic ductal adenocarcinoma: from molecules towards drugs of clinical relevance","volume":"14","author":"Selvaggi","year":"2022","journal-title":"Cancers"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"616108","DOI":"10.3389\/fonc.2021.616108","article-title":"Clinicopathological prognostic factors and chemotherapeutic outcome for two histopathological types of ampulla of Vater adenocarcinoma","volume":"11","author":"Xia","year":"2021","journal-title":"Front Oncol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejso.2022.10.001","article-title":"Impact of histopathological type on the prognosis of ampullary carcinoma: a systematic review and meta-analysis","volume":"49","author":"Shin","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"R29-20250503","first-page":"156","article-title":"Focusing on desired outcomes of care after colon cancer resections; hospital variations in \u201ctextbook outcome.\u201d","volume":"39","author":"Kolfschoten","year":"2013","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.3748\/wjg.v21.i26.7933","article-title":"Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries","volume":"21","author":"Arnal","journal-title":"World J Gastroenterol WJG"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14737140.2018.1438271","article-title":"Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches","volume":"18","author":"Davidson","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1245\/s10434-011-2168-3","article-title":"Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment","volume":"19","author":"Poultsides","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R33-20250503","first-page":"3379","article-title":"Perineural invasion in cancer: a review of the literature","volume":"115","author":"Liebig","year":"2009","journal-title":"Cancer Interdiscip Int J Am Cancer Soc"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1477-2574.2012.00489.x","article-title":"Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"HPB"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/cncr.30439","article-title":"Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: a propensity score-matched analysis of a nationwide clinical oncology database","volume":"123","author":"Ecker","year":"2017","journal-title":"Cancer"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"100132","DOI":"10.1016\/j.esmoop.2021.100132","article-title":"Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy","volume":"6","author":"Bhamidipati","year":"2021","journal-title":"ESMO Open"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.3390\/cancers12092679","article-title":"Adjuvant chemotherapy for stage III colon cancer","volume":"12","author":"Taieb","year":"2020","journal-title":"Cancers"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/modpathol.2014.36","article-title":"Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma","volume":"27","author":"Jun","year":"2014","journal-title":"Mod Pathol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T01:00:24Z","timestamp":1746234024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000006129","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]}}}